Back to search results

Safety and Performance of the Hexanium TLIF System in the Treatment of Degenerative Disc Disease

Abroad (travel likely)Recruiting

Conditions

Intervertebral Disc Degeneration

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Clinique du dos Terrefort, Bruges, France

    Contact: Study coordinator (Ibrahim Obeid, Doctor) · ibrahim.obeid@gmail.com
    Contact: Principal Investigator (Ibrahim Obeid, Doctor)
    Louis Boissière, Doctor (Sub-investigator)

  • Clinique Saint Charles, Lyon, France

    Contact: Study coordinator (Emmanuel Favreul, Doctor) · emmanuel.favreul@wanadoo.fr
    Contact: Principal Investigator (Emmanuel Favreul, Doctor)

  • Hopital privé Clairval, Marseille, France

    Contact: Study coordinator (Noel Graziani, Professor) · graziani.noel@gmail.com
    Contact: Principal Investigator (Noel Graziani, Professor)

  • CHRU Nancy, Nancy, France

    Contact: Study coordinator (Nacer Mansouri, Doctor) · mansouri.nz@gmail.com
    Contact: Principal Investigator (Nacer Mansouri, Doctor)

  • Polyclinique Majorelle, Nancy, France

    Contact: Study coordinator (Aurélie Toquart, Doctor) · a.toquart@gmail.com
    Contact: Principal Investigator (Aurélie Toquart, Doctor)

  • Clinicque Générale Beaulieu, Geneva, Switzerland

    Contact: Study coordinator (Frédéric Schils, Doctor) · fs@schilsneurosurgery.com
    Contact: Principal Investigator (Frédéric Schils, Doctor)
    Renato Gondar, Doctor (Sub-investigator)
Study leads

  • Noel Graziani, Professor

    Principal Investigator

    Hopital Privé Clairval

View source on ClinicalTrials.gov(opens in a new tab)